This year’s annual meeting of the American Society of Clinical Oncology (ASCO), which ended on Tuesday, provided many examples of emerging therapies that offer new hope to even those patients with metastatic disease.
John Otrompke
Advertisement
Articles by John Otrompke
Advertisement
Latest Updated Articles
- Drug Innovation: Alive and Well at ASCO!
Published: June 6th 2012 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
Study Claims Ozempic Lowers Biological Age
3
GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate
4
Pharmaceutical Executive Daily: New Research Suggests Ozempic May Reduce Biological Age
5
